BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19093281)

  • 1. Pharmacokinetics and pharmacodynamics of inhaled glucocorticoids.
    Padden J; Skoner D; Hochhaus G
    J Asthma; 2008; 45 Suppl 1():13-24. PubMed ID: 19093281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids.
    Hübner M; Hochhaus G; Derendorf H
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):469-88. PubMed ID: 16054538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.
    Rohatagi S; Appajosyula S; Derendorf H; Szefler S; Nave R; Zech K; Banerji D
    J Clin Pharmacol; 2004 Jan; 44(1):37-47. PubMed ID: 14681340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid pharmacokinetic/pharmacodynamic parameters and their relationship to safety and efficacy.
    Derendorf H
    Allergy Asthma Proc; 2005; 26(5):327-35. PubMed ID: 16450564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
    Derendorf H; Nave R; Drollmann A; Cerasoli F; Wurst W
    Eur Respir J; 2006 Nov; 28(5):1042-50. PubMed ID: 17074919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems.
    Tayab ZR; Hochhaus G
    Expert Opin Drug Deliv; 2005 May; 2(3):519-32. PubMed ID: 16296772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Difficulties in determining of the equivalent doses of inhaled glucocorticoids].
    Grzanka A; Jarzab J
    Pol Merkur Lekarski; 2010 Feb; 28(164):134-7. PubMed ID: 20369743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety.
    Derendorf H
    Respir Med; 1997 Nov; 91 Suppl A():22-8. PubMed ID: 9474364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of inhaled corticosteroids: an update.
    Kelly HW
    Ann Pharmacother; 2009 Mar; 43(3):519-27. PubMed ID: 19261959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.
    Derendorf H
    J Clin Pharmacol; 2007 Jun; 47(6):782-9. PubMed ID: 17412829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
    Kim D; Glaum M; Lockey R
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic and pharmacokinetic considerations in choosing an inhaled corticosteroid.
    Colice GL
    Treat Respir Med; 2006; 5(4):245-53. PubMed ID: 16808544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids.
    Winkler J; Hochhaus G; Derendorf H
    Proc Am Thorac Soc; 2004; 1(4):356-63. PubMed ID: 16113458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in corticosteroids.
    Hochhaus G
    Proc Am Thorac Soc; 2004; 1(3):269-74. PubMed ID: 16113445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
    Agertoft L; Pedersen S
    Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological approach to evaluate aerosol pulmonary deposition.
    Girodet PO; Molimard M
    J Aerosol Med; 2005; 18(2):183-92. PubMed ID: 15966772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New asthma drugs: small molecule inhaled corticosteroids.
    Gentile DA; Skoner DP
    Curr Opin Pharmacol; 2010 Jun; 10(3):260-5. PubMed ID: 20561819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma.
    Millan DS; Ballard SA; Chunn S; Dybowski JA; Fulton CK; Glossop PA; Guillabert E; Hewson CA; Jones RM; Lamb DJ; Napier CM; Payne-Cook TA; Renery ER; Selby MD; Tutt MF; Yeadon M
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5826-30. PubMed ID: 21880489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhaled glucocorticosteroids in the treatment of asthma and chronic obstructive pulmonary disease].
    Obojski A; Dobek R; Panaszek B
    Pneumonol Alergol Pol; 2004; 72(5-6):226-32. PubMed ID: 15757265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.